Skip to main content
. 2016 Apr;8(4):665–672. doi: 10.21037/jtd.2016.03.02

Figure 6.

Figure 6

Five-year overall survival of Masaoka-Koga pStaging III patients in the direct surgery group was significantly higher than Masaoka-Koga pStage I–III patients in the induction therapy group (85.2% vs. 68.1%, P=0.000).